This webinar will focus on the critical chemistry, manufacturing and controls (CMC) elements of a product’s life cycle and how Lonza applies its knowledge and experience to provide the regulatory submissions support and strategy necessary for a successful biologics licence application (BLA). You can also learn how Lonza tailors and shortens a development timeline should a product be approved for one of the US Food and Drug Administration's expedited pathways to market.
You may also be interested in:
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center